266 related articles for article (PubMed ID: 24803039)
1. Patient-reported voice and speech outcomes after whole-neck intensity modulated radiation therapy and chemotherapy for oropharyngeal cancer: prospective longitudinal study.
Vainshtein JM; Griffith KA; Feng FY; Vineberg KA; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):973-980. PubMed ID: 24803039
[TBL] [Abstract][Full Text] [Related]
2. Omitting the lower neck and sparing the glottic larynx in node-negative nasopharyngeal carcinoma was safe and feasible, and improved patient-reported voice outcomes.
Xiao F; Dou S; Li Y; Qian W; Liang F; Kong L; Wang X; Wu K; Hu C; Zhu G
Clin Transl Oncol; 2019 Jun; 21(6):781-789. PubMed ID: 30515646
[TBL] [Abstract][Full Text] [Related]
3. Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.
Vainshtein JM; Moon DH; Feng FY; Chepeha DB; Eisbruch A; Stenmark MH
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):925-33. PubMed ID: 25832685
[TBL] [Abstract][Full Text] [Related]
4. Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes.
Hunter KU; Schipper M; Feng FY; Lyden T; Haxer M; Murdoch-Kinch CA; Cornwall B; Lee CS; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):935-40. PubMed ID: 23040224
[TBL] [Abstract][Full Text] [Related]
5. Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.
Little M; Schipper M; Feng FY; Vineberg K; Cornwall C; Murdoch-Kinch CA; Eisbruch A
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1007-14. PubMed ID: 22056067
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy.
Sapir E; Tao Y; Feng F; Samuels S; El Naqa I; Murdoch-Kinch CA; Feng M; Schipper M; Eisbruch A
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):354-361. PubMed ID: 27473816
[TBL] [Abstract][Full Text] [Related]
7. Pre- and posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: expert listeners' and patient's perception.
van der Molen L; van Rossum MA; Jacobi I; van Son RJ; Smeele LE; Rasch CR; Hilgers FJ
J Voice; 2012 Sep; 26(5):664.e25-33. PubMed ID: 22209059
[TBL] [Abstract][Full Text] [Related]
8. Assessment of voice, speech, and related quality of life in advanced head and neck cancer patients 10-years+ after chemoradiotherapy.
Kraaijenga SA; Oskam IM; van Son RJ; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW; van der Molen L
Oral Oncol; 2016 Apr; 55():24-30. PubMed ID: 26874554
[TBL] [Abstract][Full Text] [Related]
9. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.
Schwartz DL; Hutcheson K; Barringer D; Tucker SL; Kies M; Holsinger FC; Ang KK; Morrison WH; Rosenthal DI; Garden AS; Dong L; Lewin JS
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1356-65. PubMed ID: 20646872
[TBL] [Abstract][Full Text] [Related]
10. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
11. Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.
Ho KF; Marchant T; Moore C; Webster G; Rowbottom C; Penington H; Lee L; Yap B; Sykes A; Slevin N
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e375-82. PubMed ID: 22197229
[TBL] [Abstract][Full Text] [Related]
12. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates.
Eisbruch A; Kim HM; Feng FY; Lyden TH; Haxer MJ; Feng M; Worden FP; Bradford CR; Prince ME; Moyer JS; Wolf GT; Chepeha DB; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e93-9. PubMed ID: 21592678
[TBL] [Abstract][Full Text] [Related]
13. Speech and voice outcomes in oropharyngeal cancer and evaluation of the University of Washington Quality of Life speech domain.
Thomas L; Jones TM; Tandon S; Carding P; Lowe D; Rogers S
Clin Otolaryngol; 2009 Feb; 34(1):34-42. PubMed ID: 19260883
[TBL] [Abstract][Full Text] [Related]
14. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
15. Radiation dose to the tongue and velopharynx predicts acoustic-articulatory changes after chemo-IMRT treatment for advanced head and neck cancer.
Jacobi I; Navran A; van der Molen L; Heemsbergen WD; Hilgers FJ; van den Brekel MW
Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):487-94. PubMed ID: 25638526
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.
Feng FY; Kim HM; Lyden TH; Haxer MJ; Feng M; Worden FP; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1289-98. PubMed ID: 17560051
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
[TBL] [Abstract][Full Text] [Related]
18. Single Vocal Cord Irradiation: Image Guided Intensity Modulated Hypofractionated Radiation Therapy for T1a Glottic Cancer: Early Clinical Results.
Al-Mamgani A; Kwa SL; Tans L; Moring M; Fransen D; Mehilal R; Verduijn GM; Baatenburg de Jong RJ; Heijmen BJ; Levendag PC
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):337-43. PubMed ID: 26264629
[TBL] [Abstract][Full Text] [Related]
19. Prospective functional outcomes in sequential population based cohorts of stage III/ IV oropharyngeal carcinoma patients treated with 3D conformal vs. intensity modulated radiotherapy.
Kerr P; Myers CL; Butler J; Alessa M; Lambert P; Cooke AL
J Otolaryngol Head Neck Surg; 2015 May; 44(1):17. PubMed ID: 25964113
[TBL] [Abstract][Full Text] [Related]
20. Impact of selective neck dissection on chronic dysphagia after chemo-intensity-modulated radiotherapy for oropharyngeal carcinoma.
Hutcheson KA; Abualsamh AR; Sosa A; Weber RS; Beadle BM; Sturgis EM; Lewin JS
Head Neck; 2016 Jun; 38(6):886-93. PubMed ID: 26339764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
